Literature DB >> 18339458

Retracing our STEP towards a successful CTL-based HIV-1 vaccine.

Otto O Yang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18339458      PMCID： PMC2467453          DOI： 10.1016/j.vaccine.2008.02.027

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  41 in total

1.  Selection on the human immunodeficiency virus type 1 proteome following primary infection.

Authors:  Yi Liu; John McNevin; Jianhong Cao; Hong Zhao; Indira Genowati; Kim Wong; Sherry McLaughlin; Matthew D McSweyn; Kurt Diem; Claire E Stevens; Janine Maenza; Hongxia He; David C Nickle; Daniel Shriner; Sarah E Holte; Ann C Collier; Lawrence Corey; M Juliana McElrath; James I Mullins
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.

Authors:  Michael S Bennett; Hwee L Ng; Mirabelle Dagarag; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

3.  Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.

Authors:  Sheri Dubey; James Clair; Tong-Ming Fu; Liming Guan; Romnie Long; Robin Mogg; Kiersten Anderson; Kelly B Collins; Christine Gaunt; V Rose Fernandez; Lan Zhu; Lisa Kierstead; Scott Thaler; Swati B Gupta; Walter Straus; Devan Mehrotra; Timothy W Tobery; Danilo R Casimiro; John W Shiver
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

4.  Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.

Authors:  Laura E Valentine; Shari M Piaskowski; Eva G Rakasz; Nathan L Henry; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

5.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

6.  Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.

Authors:  Annette Oxenius; David A Price; Alexandra Trkola; Charles Edwards; Emma Gostick; Hua-Tang Zhang; Philippa J Easterbrook; Tin Tun; Andrew Johnson; Anele Waters; Edward C Holmes; Rodney E Phillips
Journal:  J Infect Dis       Date:  2004-07-20       Impact factor: 5.226

7.  Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity.

Authors:  Michael S Bennett; Hwee L Ng; Ayub Ali; Otto O Yang
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

8.  Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.

Authors:  J William Critchfield; Donna Lemongello; Digna H Walker; Juan C Garcia; David M Asmuth; Richard B Pollard; Barbara L Shacklett
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

9.  Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.

Authors:  Annika C Karlsson; Astrid K N Iversen; Joan M Chapman; Tulio de Oliviera; Gerald Spotts; Andrew J McMichael; Miles P Davenport; Frederick M Hecht; Douglas F Nixon
Journal:  PLoS One       Date:  2007-02-21       Impact factor: 3.240

10.  Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.

Authors:  P J Goulder; M A Altfeld; E S Rosenberg; T Nguyen; Y Tang; R L Eldridge; M M Addo; S He; J S Mukherjee; M N Phillips; M Bunce; S A Kalams; R P Sekaly; B D Walker; C Brander
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307
View more
  7 in total

Review 1.  T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.

Authors:  Bette T Korber; Norman L Letvin; Barton F Haynes
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

Review 2.  Pirate primates in uncharted waters: lymphocyte transfers in unrelated, MHC-matched macaques.

Authors:  Benjamin J Burwitz; Justin M Greene; David H O'Connor
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

3.  Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.

Authors:  Nancy A Wilson; Brandon F Keele; Jason S Reed; Shari M Piaskowski; Caitlin E MacNair; Andrew J Bett; Xiaoping Liang; Fubao Wang; Elizabeth Thoryk; Gwendolyn J Heidecker; Michael P Citron; Lingyi Huang; Jing Lin; Salvatore Vitelli; Chanook D Ahn; Masahiko Kaizu; Nicholas J Maness; Matthew R Reynolds; Thomas C Friedrich; John T Loffredo; Eva G Rakasz; Stephen Erickson; David B Allison; Michael Piatak; Jeffrey D Lifson; John W Shiver; Danilo R Casimiro; George M Shaw; Beatrice H Hahn; David I Watkins
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 4.  Relevance of studying T cell responses in SIV-infected rhesus macaques.

Authors:  Laura E Valentine; David I Watkins
Journal:  Trends Microbiol       Date:  2008-10-27       Impact factor: 17.079

5.  T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.

Authors:  Mauricio A Martins; Nancy A Wilson; Jason S Reed; Chanook D Ahn; Yann C Klimentidis; David B Allison; David I Watkins
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

6.  Efficiency of recombinant bacille Calmette-Guérin in inducing humoral and cell mediated immunities against human immunodeficiency virus type 1 third variable domain in immunized mice.

Authors:  Young Jae Kim
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

7.  Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation.

Authors:  Otto O Yang
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.